1 report

  • JAN 16, 2018: BIOELECTRONICS ANNOUNCES EXPANDED MENSTRUAL PAIN STUDY
  • BIOELECTRONICS CORP - KEY FACTS

WITH THE ADDITION OF ACTIPATCH TO LIST OF APPROVED TREATMENTS, CHRONIC PAIN SUFFERERS NOW HAVE ACCESS TO PAID SAFE, DRUG-FREE CHRONIC PAIN RELIEF.

  • Chronic Pain
  • Clinical Trial
  • Pain Relief
  • Therapy
  • BioElectronics Corporation